Related Experiment Video

Updated: Apr 21, 2026

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
13:51

Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay

Published on: November 11, 2018

9.4K

Molecular pathways: targeting the kinase effectors of RHO-family GTPases

Tatiana Y Prudnikova1, Sonali J Rawat2, Jonathan Chernoff3

  • 1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|October 23, 2014
PubMed

Insights

RHO GTPases are key regulators in cancer development. Inhibiting these proteins or their effectors shows promise as a novel cancer therapeutic strategy.

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • RHO GTPases are critical molecular switches activated by adhesion and growth factors.
  • They are involved in crucial cellular processes like tumor development and progression.
  • Key RHO-family GTPases include RAC1, CDC42, and RHOA, which signal through various effector proteins.

Purpose of the Study:

  • To explore the therapeutic potential of targeting RHO GTPases and their downstream effectors in cancer.
  • To review the development of small-molecule inhibitors for RHO GTPases and their associated protein kinases.

Main Methods:

  • This study reviews existing research on RHO GTPase signaling pathways in cancer.
  • It focuses on the development and potential application of small-molecule inhibitors.

Main Results:

  • Loss of RHO function inhibits transformation induced by oncogenic stimuli.
  • Small-molecule inhibitors targeting RHO GTPases or their downstream kinases are under development.
  • These inhibitors represent a promising strategy for cancer therapy.

Conclusions:

  • Targeting RHO GTPases and their downstream signaling kinases is a viable therapeutic strategy for cancer.
  • Pharmaceutical research is actively pursuing these inhibitors for clinical use.
  • Despite not being widely adopted yet, these inhibitors hold significant promise for cancer treatment.

More Related Videos

RhoC GTPase Activation Assay09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

12.2K
Affinity Precipitation of Active Rho-GEFs Using a GST-tagged Mutant Rho Protein GST-RhoAG17A from Epithelial Cell Lysates11:28

Affinity Precipitation of Active Rho-GEFs Using a GST-tagged Mutant Rho Protein GST-RhoAG17A from Epithelial Cell Lysates

Published on: March 31, 2012

18.4K

Related Concept Videos

Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.6K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
14.9K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Cell Polarization by Rho Proteins01:21

Cell Polarization by Rho Proteins

Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
3.1K